Single Dose of HPV Vaccine May Cut Preinvasive Cervical Disease

Risk for preinvasive cervical disease decreased with one, two, three vaccine doses at age 15 to 19 years
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Infections, Internal Medicine, Nursing, Oncology, Pediatrics, Pharmacy, Journal, Source Type: news

Related Links:

Microsoft founder says developing world needs help in fighting pandemic
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
(WASHINGTON) — In a first, small step toward reopening the country, the Trump administration issued new guidelines Wednesday to make it easier for essential workers who have been exposed to COVID-19 to get back to work if they do not have symptoms of the coronavirus. Dr. Robert Redfield, director of the the Centers for Disease Control and Prevention, announced at the White House that essential employees, such as health care and food supply workers, who have been within 6 feet of a confirmed or suspected case of the virus can return to work under certain circumstances if they are not experiencing symptoms. The new gu...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 overnight wire Source Type: news
U.S. researchers have opened another safety test of an experimental COVID-19 vaccine, this one using a skin-deep shot instead of the usual deeper jab
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
BOSTON (CBS) — TPA is a drug that is used to help stroke and heart attack victims. It works by breaking up or busting blood clots. Doctors at Beth Israel Deaconess Medical Center are now using it in a clinical trial on gravely ill coronavirus patients. “There’s a lot of very small blood clots accumulating in the lungs of these patients,” said Dr. Christopher Barrett. “And that seems to be at least contributory, if not the predominant reason, that their respiratory failure is so bad.” Dr. Barrett says TPA could help patients recover faster, free up ventilators and even prevent people from...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health Syndicated CBSN Boston Syndicated Local Cheryl Fiandaca Coronavirus Health News Source Type: news
China ’s restrictions have brought the first wave to an end but the danger of a second is very realCoronavirus – latest updatesSee all our coronavirus coverageCountries wanting to end the lockdown and allow people to move about and work again will have to monitor closely for new infections and adjust the controls they have in place untilthere is a vaccine against Covid-19, according to a new study based on the Chinese experience.China ’saggressive controls over daily life have brought the first wave of Covid-19 to an end, say researchers based in Hong Kong. But the danger of a second wave is very real.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak World news Science China Vaccines and immunisation Health Infectious diseases Source Type: news
ConclusionsBirth characteristics, household-level determinants and country-level characteristics seem to be more closely related to maternal and child healthcare utilization as well as child health outcomes than whether the pregnancy was wanted or unwanted in LMICs.
Source: International Journal of Public Health - Category: International Medicine & Public Health Source Type: research
(Natural News) As we’ve been covering the coronavirus pandemic, I still haven’t been able to communicate the full magnitude of what has been unleashed upon the world and what it means to you, dear reader. It’s a safe bet that half of the people reading this won’t be alive by 2025. And that’s all by...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
Structural data on the complex could guide drug and vaccine design
Source: Chemical and Engineering News - Category: Chemistry Authors: Source Type: research
Just three months after the start of the coronavirus pandemic, several biotech companies are beginning trials of promising vaccines and treatments.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Vaccination and Immunization Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Clinical Trials Epidemics Immune System Research DNA (Deoxyribonucleic Acid) RNA (Ribonucleic Acid) Biotechnology and Bioengineering Food and Drug Administrat Source Type: news
CONCLUSIONS: The season was delayed by sustained VRS circulation. The VE was lower than the national one. It is be essential to promote future campaigns to improve vaccination coverage. PMID: 32252987 [PubMed - as supplied by publisher]
Source: Medicina Clinica - Category: General Medicine Tags: Med Clin (Barc) Source Type: research
More News: Cancer & Oncology | Internal Medicine | Nurses | Nursing | Pediatrics | Vaccines